Tag: European Co

ALX Oncology gets EC’s orphan drug status for evorpacept in gastric cancer

ALX Oncology Holdings, an Australian immuno-oncology company focusing on CD47 checkpoint pathway blocking therapies, declared a significant milestone with its flagship drug candidate evorpacept securing ... Read More